Dr Kent Eugene Miller, MD | |
Caterpillar Inc, 100 Tractor Drive, Bldg. Ss, Medical Dept., East Peoria, IL 61630-0001 | |
(309) 494-2559 | |
(309) 675-7773 |
Full Name | Dr Kent Eugene Miller |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | Caterpillar Inc, East Peoria, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336368083 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kent Eugene Miller, MD Caterpillar Inc, 100 Tractor Drive, Bldg. Ss, Medical Dept., East Peoria, IL 61630-0001 Ph: (309) 494-2559 | Dr Kent Eugene Miller, MD Caterpillar Inc, 100 Tractor Drive, Bldg. Ss, Medical Dept., East Peoria, IL 61630-0001 Ph: (309) 494-2559 |
News Archive
A popular new ingredient in gluten-free products could be causing an allergic reaction, according to a Kansas State University food safety specialist.
Researchers at the Children's Medical Center Research Institute at UT Southwestern have identified genetic mutations that accumulate in the adult liver that can promote regeneration in the context of chronic liver damage.
Vermont regulators on Monday announced monthly rates for health insurance to be sold under Vermont Health Connect, the health insurance exchange being set up to comply with the federal Affordable Care Act. Middle- and upper-class consumers who begin buying through Vermont Health Connect when it takes hold of Vermont's individual and small-group health insurance markets in January won't notice much difference in costs of insurance and benefits provided (Gram, 7/8).
A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.
› Verified 4 days ago